HRSA-26-015: State Loan Repayment Program (State LRP)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Health Resources and Services Administration notices from 2025.
Health Resources and Services Administration offered grants of up to $1.0 million to state and local governments and tribes. It expected to make about 50 awards worth $20.0 million in total. Applications closed on January 12, 2026.
From the official notice on Grants.gov, last changed July 24, 2025. Checked November 7, 2026.
- Award ceiling$1.0 million
- Total funding$20.0 million
- Expected awards50
- Cost sharingRequired
- Funding typeGrant
Key dates
| Posted | July 24, 2025 |
|---|---|
| Deadline | January 12, 2026 |
Who can apply
This opportunity was open to state and local governments and tribes.
- State governments
- Special district governments
- Native American tribal governments (Federally recognized)
- Native American tribal organizations (other than Federally recognized tribal governments)
Domestic organizations may apply. "Domestic" means the 50 states, the District of Columbia, the Commonwealth of Puerto Rico, the Northern Mariana Islands, American Samoa, Guam, the U.S. Virgin Islands, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau. Individuals are not eligible applicants under this NOFO.
Is this a realistic fit?
- Past Grants to States for Loan Repayment awards averaged $1.4 million; this notice allows up to $1.0 million per award.
- The notice requires cost sharing or matching funds, so you must contribute part of the project cost.
What the grant funds
The purpose of the State Loan Repayment Program (State LRP) is to make grants to States, the District of Columbia, and U.S. Territories to assist them in operating their own state educational loan repayment programs for primary care providers working in Health Professional Shortage Areas (HPSAs) within their State.
Who has won Grants to States for Loan Repayment grants before
From fiscal 2021 to 2025, Grants to States for Loan Repayment (93.165) awarded $108 million across 80 grant awards, an average of $1.4 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Colorado Department of Public Health & Environment | Colorado | 2 | $4.0 million |
| Arizona Department of Health Services | Arizona | 2 | $4.0 million |
| California Department of Health Care Access and Information | California | 2 | $4.0 million |
| Michigan Department of Health and Human Services | Michigan | 2 | $3.9 million |
| Pennsylvania Department of Health | Pennsylvania | 2 | $3.8 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is HRSA-26-015 still open?
No. It closed on January 12, 2026.
Who can apply for State Loan Repayment Program (State LRP)?
Health Resources and Services Administration accepted applications from state and local governments and tribes. The notice adds further conditions, so read its eligibility section.
What is the deadline for State Loan Repayment Program (State LRP)?
Closed January 12, 2026. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $1.0 million each. About $20.0 million in total across about 50 awards.
Who has won Grants to States for Loan Repayment grants before?
The largest recipients over five fiscal years were Colorado Department of Public Health & Environment, Arizona Department of Health Services, California Department of Health Care Access and Information. The program made 80 awards worth $108 million in that time.
Similar open grants
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
- Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)